Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

1.

Antibiotic treatment decreases microbial burden associated with pseudomyxoma peritonei and affects β-catenin distribution.

Semino-Mora C, Testerman TL, Liu H, Whitmire JM, Studeman K, Jia Y, McAvoy TJ, Francis J, Nieroda C, Sardi A, Merrell DS, Dubois A.

Clin Cancer Res. 2013 Jul 15;19(14):3966-76. doi: 10.1158/1078-0432.CCR-13-0616. Epub 2013 Jun 6.

PMID:
23743566
[PubMed - indexed for MEDLINE]
Free Article
2.

Pseudomyxoma peritonei: is disease progression related to microbial agents? A study of bacteria, MUC2 AND MUC5AC expression in disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis.

Semino-Mora C, Liu H, McAvoy T, Nieroda C, Studeman K, Sardi A, Dubois A.

Ann Surg Oncol. 2008 May;15(5):1414-23. doi: 10.1245/s10434-007-9778-9. Epub 2008 Feb 26.

PMID:
18299935
[PubMed - indexed for MEDLINE]
Free PMC Article
3.
4.

Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis.

Ronnett BM, Yan H, Kurman RJ, Shmookler BM, Wu L, Sugarbaker PH.

Cancer. 2001 Jul 1;92(1):85-91.

PMID:
11443613
[PubMed - indexed for MEDLINE]
5.

Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).

Baratti D, Kusamura S, Nonaka D, Langer M, Andreola S, Favaro M, Gavazzi C, Laterza B, Deraco M.

Ann Surg Oncol. 2008 Feb;15(2):526-34. Epub 2007 Nov 28.

PMID:
18043976
[PubMed - indexed for MEDLINE]
6.

Pseudomyxoma peritonei of appendiceal origin: a clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review.

Bradley RF, Stewart JH 4th, Russell GB, Levine EA, Geisinger KR.

Am J Surg Pathol. 2006 May;30(5):551-9.

PMID:
16699309
[PubMed - indexed for MEDLINE]
7.

Mucinous tumors arising in ovarian mature cystic teratomas: relationship to the clinical syndrome of pseudomyxoma peritonei.

Ronnett BM, Seidman JD.

Am J Surg Pathol. 2003 May;27(5):650-7.

PMID:
12717249
[PubMed - indexed for MEDLINE]
8.

[Histologic classification and prognostic implication of pseudomyxoma peritonei].

Guo AT, Wei LX, Song X.

Zhonghua Bing Li Xue Za Zhi. 2007 Jul;36(7):474-9. Chinese.

PMID:
17845762
[PubMed - indexed for MEDLINE]
9.

Feasibility of peritonectomy associated with intraperitoneal hyperthermic perfusion in patients with Pseudomyxoma peritonei.

Deraco M, Gronchi A, Mazzaferro V, Inglese MG, Pennacchioli E, Kusamura S, Rizzi M, Anselmi RA Jr, Vaglini M.

Tumori. 2002 Sep-Oct;88(5):370-5.

PMID:
12487553
[PubMed - indexed for MEDLINE]
10.

A core microbiome associated with the peritoneal tumors of pseudomyxoma peritonei.

Gilbreath JJ, Semino-Mora C, Friedline CJ, Liu H, Bodi KL, McAvoy TJ, Francis J, Nieroda C, Sardi A, Dubois A, Lazinski DW, Camilli A, Testerman TL, Merrell DS.

Orphanet J Rare Dis. 2013 Jul 12;8:105. doi: 10.1186/1750-1172-8-105.

PMID:
23844722
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.

Vaira M, Cioppa T, DE Marco G, Bing C, D'Amico S, D'Alessandro M, Fiorentini G, DE Simone M.

In Vivo. 2009 Jul-Aug;23(4):639-44.

PMID:
19567401
[PubMed - indexed for MEDLINE]
Free Article
12.

Pseudomyxoma peritonei of 92 Chinese patients: clinical characteristics, pathological classification and prognostic factors.

Guo AT, Li YM, Wei LX.

World J Gastroenterol. 2012 Jun 28;18(24):3081-8. doi: 10.3748/wjg.v18.i24.3081.

PMID:
22791943
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Pleural extension of mucinous tumor in patients with pseudomyxoma peritonei syndrome.

Pestieau SR, Esquivel J, Sugarbaker PH.

Ann Surg Oncol. 2000 Apr;7(3):199-203.

PMID:
10791850
[PubMed - indexed for MEDLINE]
14.

Gelatinous ascites: a cytohistologic study of pseudomyxoma peritonei in 67 patients.

Jackson SL, Fleming RA, Loggie BW, Geisinger KR.

Mod Pathol. 2001 Jul;14(7):664-71.

PMID:
11454998
[PubMed - indexed for MEDLINE]
Free Article
15.

Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Smeenk RM, Verwaal VJ, Antonini N, Zoetmulder FA.

Ann Surg. 2007 Jan;245(1):104-9.

PMID:
17197972
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Treating pseudomyxoma peritonei without heated intraperitoneal chemotherapy--a first look in New Zealand.

Wheeler BR, Reddy SK, Kenwright D, Keating JP.

N Z Med J. 2014 Feb 14;127(1389):31-9.

PMID:
24548955
[PubMed - indexed for MEDLINE]
17.

Histopathologic analysis in 46 patients with pseudomyxoma peritonei syndrome: failure versus success with a second-look operation.

Yan H, Pestieau SR, Shmookler BM, Sugarbaker PH.

Mod Pathol. 2001 Mar;14(3):164-71.

PMID:
11266521
[PubMed - indexed for MEDLINE]
Free Article
18.

Commentary on 'Survival of patients with pseudomyxoma peritonei treated by serial debulking'.

Moran BJ.

Colorectal Dis. 2010 Sep;12(9):872-3. doi: 10.1111/j.1463-1318.2010.02340.x. No abstract available.

PMID:
20718839
[PubMed - indexed for MEDLINE]
19.

[Pseudomyxoma peritonei--a case report].

Iarŭmov N, Terziev I, Toshev S, Angelov K, Velev G, Todorov G, Koĭchev A, Ilinov V.

Khirurgiia (Sofiia). 2006;(3):15-9. Bulgarian.

PMID:
18788112
[PubMed - indexed for MEDLINE]
20.

Prognostic significance of single isolated cells with decreased E-cadherin expression in pseudomyxoma peritonei.

Koh YW, Jun SY, Kim KR.

Pathol Int. 2014 Apr;64(4):164-72. doi: 10.1111/pin.12157.

PMID:
24750186
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk